These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 25889203)

  • 1. Mesenchymal stem cells-regulated Treg cells suppress colitis-associated colorectal cancer.
    Tang RJ; Shen SN; Zhao XY; Nie YZ; Xu YJ; Ren J; Lv MM; Hou YY; Wang TT
    Stem Cell Res Ther; 2015 Apr; 6(1):71. PubMed ID: 25889203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical cord-derived mesenchymal stem cells downregulate inflammatory responses by shifting the Treg/Th17 profile in experimental colitis.
    Li L; Liu S; Xu Y; Zhang A; Jiang J; Tan W; Xing J; Feng G; Liu H; Huo F; Tang Q; Gu Z
    Pharmacology; 2013; 92(5-6):257-64. PubMed ID: 24280970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells can prevent or promote the progression of colon cancer based on their timing of administration.
    Hu W; Wang W; Jiang X; Wang Z; Lin R
    J Transl Med; 2023 Mar; 21(1):227. PubMed ID: 36978120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.
    Nam YS; Kim N; Im KI; Lim JY; Lee ES; Cho SG
    World J Gastroenterol; 2015 Feb; 21(7):2030-9. PubMed ID: 25717235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
    Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH
    World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenteric lymph nodes: a critical site for the up-regulatory effect of hUC-MSCs on Treg cells by producing TGF-β1 in colitis treatment.
    Zhang Q; Zeng Z; Wei N; Su Y; Wang J; Ni Q; Wang Y; Yang J; Liu X; Xu H; Wang G; Shan Y; Zhou F
    Stem Cell Res Ther; 2024 Jul; 15(1):190. PubMed ID: 38956621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.
    Sala E; Genua M; Petti L; Anselmo A; Arena V; Cibella J; Zanotti L; D'Alessio S; Scaldaferri F; Luca G; Arato I; Calafiore R; Sgambato A; Rutella S; Locati M; Danese S; Vetrano S
    Gastroenterology; 2015 Jul; 149(1):163-176.e20. PubMed ID: 25790743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
    Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
    Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.
    Suzuki R; Fukui T; Kishimoto M; Miyamoto S; Takahashi Y; Takeo M; Mitsuyama T; Sakaguchi Y; Uchida K; Nishio A; Okazaki K
    J Crohns Colitis; 2015 Jul; 9(7):565-74. PubMed ID: 25908723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases.
    Li CL; Leng Y; Zhao B; Gao C; Du FF; Jin N; Lian QZ; Xu SY; Yan GL; Xia JJ; Zhuang GH; Fu QL; Qi ZQ
    Stem Cells; 2017 Jul; 35(7):1719-1732. PubMed ID: 28520232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
    Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
    World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
    Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
    Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor enhances the inflammation-alleviating effect of umbilical cord-derived mesenchymal stromal cells in a bronchiolitis obliterans model.
    Cao XP; Han DM; Zhao L; Guo ZK; Xiao FJ; Zhang YK; Zhang XY; Wang LS; Wang HX; Wang H
    Cytotherapy; 2016 Mar; 18(3):402-12. PubMed ID: 26857230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice.
    Jo H; Eom YW; Kim HS; Park HJ; Kim HM; Cho MY
    Gut Liver; 2018 Nov; 12(6):664-673. PubMed ID: 29938461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5(+) B regulatory cells.
    Chao K; Zhang S; Qiu Y; Chen X; Zhang X; Cai C; Peng Y; Mao R; Pevsner-Fischer M; Ben-Horin S; Elinav E; Zeng Z; Chen B; He Y; Xiang AP; Chen M
    Stem Cell Res Ther; 2016 Aug; 7(1):109. PubMed ID: 27515534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.
    Chao YH; Wu HP; Wu KH; Tsai YG; Peng CT; Lin KC; Chao WR; Lee MS; Fu YC
    PLoS One; 2014; 9(10):e110338. PubMed ID: 25337817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early injection of human adipose tissue-derived mesenchymal stem cell after inflammation ameliorates dextran sulfate sodium-induced colitis in mice through the induction of M2 macrophages and regulatory T cells.
    Kawata Y; Tsuchiya A; Seino S; Watanabe Y; Kojima Y; Ikarashi S; Tominaga K; Yokoyama J; Yamagiwa S; Terai S
    Cell Tissue Res; 2019 May; 376(2):257-271. PubMed ID: 30635774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.
    Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH
    World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.